Kane Biotech (TSE:KNE) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Kane Biotech, a company specializing in biofilm research, has expanded its global reach with a new three-year distribution agreement for its revyve™ Antimicrobial Wound Gel in Qatar. This marks Kane Biotech’s second distribution deal in the Middle East, reflecting the company’s continuous effort to commercialize their product internationally. The agreement is expected to strengthen Kane Biotech’s presence in the global wound care market.
For further insights into TSE:KNE stock, check out TipRanks’ Stock Analysis page.